Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

ADHD and OCD Together: Why the Order of Treatment Matters as Much as the Treatment

Clinically reviewed by Wendy Delgado, PA-C

Reviewed November 5, 2026 · Last updated November 5, 2026

Key Takeaways

  • ADHD and OCD can occur together. Across more than 35 studies, an average of 21% of children and 8.5% of adults with OCD also had ADHD, though reported rates vary widely.
  • OCD can produce attention problems that look like ADHD. In a study of 50 young people treated for OCD, inattention eased as OCD improved, but hyperactivity and impulsivity may not.
  • Order matters. Researchers suggest treating OCD first when inattention is the main ADHD-type symptom, while prominent impulsivity may need stabilizing before intensive OCD therapy.
  • Some ADHD and OCD medications interact. The Adderall XR label warns about serotonin syndrome with SSRIs, and atomoxetine needs a lower starting dose with fluoxetine or paroxetine.
  • Evidence on stimulants in OCD is limited and mixed. Report new or longer rituals, intrusive thoughts, or tics after any ADHD medication change.

Maybe your ADHD medication sharpened your focus, and your checking rituals seemed to sharpen with it. Or maybe your OCD treatment is going well, but deadlines still slip past you. When you live with both conditions, fixing one can quietly change the other.

The two conditions involve the same brain circuit pulling in opposite directions. An IOCDF expert article explains that the frontostriatal system tends to be overactive in OCD and underactive in ADHD, yet both conditions impair planning, task switching, and working memory. Treating one without disturbing the other takes precision.

Each condition has well-established treatments. NIMH’s OCD guide describes exposure and response prevention (ERP) and serotonin reuptake inhibitors as the core OCD treatments, and a CDC report on adult ADHD notes that medication is a first-line treatment for adults with ADHD. The results are real, and the science is well established.

Each treatment works on its own, but research on treating both conditions together is thin, and at Siggy we think that gap calls for more care in sequencing, never less.

A sequenced plan decides which condition to treat first, checks every medication pairing against its FDA label, and watches whether attention problems fade as OCD improves. It uses the same treatments in a deliberate order, and it follows from how the two conditions pull one brain circuit in opposite directions, which is a matter of neurobiology.

What This Page Covers

How Common Is It to Have Both ADHD and OCD?

It happens, though the numbers are messy. The IOCDF article notes that more than 35 studies reported an average of 21% of children and 8.5% of adults with OCD also having ADHD. Individual studies range from 0% to 59%, and the authors suspect that a full dual diagnosis in adults is fairly rare and often comes with a tic disorder.

Several things explain the spread. A critical review of the overlap found that studies used very few community samples and widely varying criteria, and that tic disorders may inflate the overlap. Genetic evidence so far supports a shared link only in children. The authors also caution that ADHD-like symptoms caused by OCD may be misdiagnosed as ADHD, which could explain the lower rates in adults.

ADHD itself is common in adults. The CDC report found that 6.0% of U.S. adults had a current ADHD diagnosis in 2023, and more than half were diagnosed in adulthood. If you’re working out whether your focus problems come from one condition or both, our guide to telling OCD and ADHD apart walks through the clues.

Why Does Having Both Make Each One Harder?

Obsessions use up mental bandwidth. The IOCDF article describes an executive overload model: the more intrusive thoughts you’re handling in a given moment, the fewer resources remain for listening in a meeting or finishing a task. Its authors note that attention problems in OCD are largely state-dependent, so they rise and fall with OCD symptoms.

ADHD can make OCD treatment harder to stick with. A 2026 review on treatment sequencing noted that ADHD and other impulsivity-related conditions may interfere with engagement in ERP. It also noted that people with prominent impulsivity or ADHD often respond incompletely to SSRIs alone.

There’s one surprising twist. In the IOCDF authors’ research, people with ADHD who also had more obsessive-compulsive traits performed better on executive function tests, possibly because those traits added organization and attention to detail.

Which Condition Gets Treated First?

There’s no fixed rule, and the evidence comes from small studies and expert reviews. The table summarizes what a youth OCD study of 50 participants, the 2026 sequencing review, and an augmentation review from 2026 suggest:

Situation What Researchers Suggest Evidence Behind It
Inattention is the main ADHD-type symptom Treat OCD first, then reassess attention One study, 50 young people
Prominent impulsivity or hyperactivity Stabilize impulsivity before intensive ERP Narrative review
Attention still impaired after OCD improves Add ADHD-targeted treatment One study, 50 young people
OCD not responding to an SSRI, ADHD present Extended-release methylphenidate may be considered One small trial, two case series

In the youth study, people whose OCD improved more saw bigger drops in inattention, while hyperactivity and impulsivity may not decrease with OCD treatment. ADHD symptoms at the start didn’t predict how well OCD treatment worked, which is encouraging if you have both.

Questions worth asking when you plan treatment:

  • Which condition is causing the most trouble right now?
  • If we treat OCD first, when will we recheck my attention?
  • Could any of my current medications interact with an ADHD or OCD medication?
  • What changes should prompt a call before my next appointment?

Can ADHD Medication Make OCD Worse?

It can for some people, but the evidence is thin. The IOCDF article notes that several studies suggest stimulants may worsen or even trigger obsessive-compulsive thoughts and behaviors, possibly by sharpening attention toward obsessions. The 2026 augmentation review points the other way for some adults, finding that extended-release methylphenidate may be considered for carefully selected adults with both conditions, while calling for larger studies.

Tics are part of the picture too. The Adderall XR label advises checking for tics or Tourette’s syndrome before starting and watching for new or worsening tics, and tic disorders are one factor that may inflate ADHD and OCD overlap rates. For a closer look at medication types, see our guide to stimulant vs non-stimulant ADHD medications.

Which ADHD and OCD Medications Interact?

Some common pairings need a plan. These are drawn from Adderall XR’s label, Strattera’s prescribing information, and sertraline’s FDA label:

Combination What the Label Says What It Means for You
Amphetamine plus any SSRI Raises serotonin syndrome risk Lower starting doses, closer monitoring
Amphetamine plus a CYP2D6 inhibitor May raise amphetamine exposure Same caution, especially with dose increases
Atomoxetine plus fluoxetine or paroxetine Start 40 mg, raise to 80 mg only after 4 weeks Slower titration
Atomoxetine plus sertraline May raise atomoxetine exposure Atomoxetine dose may need lowering

Strattera’s label names fluoxetine and paroxetine as strong CYP2D6 inhibitors, so they also fall under the amphetamine caution in the second row. MAOIs can’t be combined with amphetamine or sertraline at all. Serotonin syndrome symptoms include agitation, fast heartbeat, sweating, muscle twitching, and high fever, and they call for urgent care. Our guide to Strattera as a non-stimulant option covers atomoxetine in more depth.

What Should You Track When You Have Both?

Because one condition can mask or mimic the other, a simple log helps your prescriber tell what’s working. Useful things to note:

  • How much time rituals or obsessions take each day
  • Whether focus problems follow intrusive thoughts or happen without them
  • Any new or longer rituals after an ADHD medication change
  • New tics, restlessness, sweating, or a racing heart after a dose change
  • Sleep and appetite, which both medication types can affect
  • Every medication and supplement you take, including St. John’s wort

NIMH notes that people with OCD often spend more than an hour a day on obsessions or compulsions, so tracking time spent is a practical yardstick. If OCD is new territory, our guide to how to treat OCD explains ERP and medication options.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat both ADHD and OCD, along with the anxiety and depression that NIMH notes commonly occur alongside OCD. Siggy’s AI therapy and daily check-ins support the work between visits, and an ERP specialist can be part of your plan.

Where Siggy helps is the full picture. The anonymous intake needs no name, email, or account, and you’ll get a downloadable summary of your symptoms, medications, doses, and side effects. That record makes it easier for every clinician on your team to check interactions and agree on what to treat first. A licensed prescriber reviews your full intake before making a diagnosis or prescribing anything.

Siggy isn’t an emergency service. If you’re in crisis, call 911 or 988 first. Never start, change, or stop a medication without talking to your prescriber. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

Bring Both Conditions Into One Clear Picture

When two conditions overlap, the most useful thing you can bring to an appointment is a clear record of what you’re feeling and what you’re taking. If medication is already part of your OCD care, our guide to medication for OCD explains dosing and timelines. Start your anonymous intake and walk away with a summary every clinician on your team can use. It’s free, a real doctor reviews every clinical decision, and the summary is yours to keep.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

Can you have ADHD and OCD at the same time?

Yes. According to the International OCD Foundation, more than 35 studies have reported that an average of 21% of children and 8.5% of adults with OCD also have ADHD. Rates vary widely, partly because obsessions can drain attention and look like ADHD, so a careful history of when each symptom began matters.

Should ADHD or OCD be treated first?

There's no fixed rule, and research on treating both together is limited. One study of young people found that inattention improved as OCD improved, and its authors suggested treating OCD before targeting inattentive ADHD. A 2026 review proposed stabilizing prominent impulsivity first, because it can interfere with exposure and response prevention (ERP). Your prescriber will weigh which symptoms impair you most.

Can I take Adderall with an SSRI?

It's sometimes done, but it takes care. The Adderall XR label warns that combining amphetamine with serotonergic drugs, including SSRIs, increases the risk of serotonin syndrome. It advises starting with lower doses and monitoring closely during the start and any dose increase. Never combine or adjust these medications without your prescriber.

Does Strattera interact with SSRIs?

It can. Strattera's label says adults taking strong CYP2D6 inhibitors, such as fluoxetine or paroxetine, should start atomoxetine at 40 mg a day and only increase to 80 mg if symptoms haven't improved after 4 weeks. Sertraline's label also lists atomoxetine among drugs whose dose may need lowering, because sertraline inhibits CYP2D6.

Can ADHD medication make OCD worse?

It can in some people, but the evidence is limited. The International OCD Foundation notes that several studies suggest stimulants may worsen or even trigger obsessive-compulsive symptoms, while a 2026 review found limited early evidence for extended-release methylphenidate as an add-on for some adults with OCD, including those with ADHD. Report any new or longer rituals to your prescriber.

Does ADHD make ERP harder?

It can. A 2026 review noted that ADHD and other impulsivity-related conditions may interfere with engagement in exposure and response prevention. It suggested that improving attention and impulse control may help some people stick with exposures, which is one reason treatment order deserves a deliberate plan.

Sources

  1. Abramovitch A, Mittelman A. OCD and ADHD: dual diagnosis, misdiagnosis and the cognitive “cost” of obsessions. International OCD Foundation. iocdf.org
  2. National Institute of Mental Health. Obsessive-Compulsive Disorder: When Unwanted Thoughts or Repetitive Behaviors Take Over. NIH Publication No. 23-MH-4676. Revised 2023. nimh.nih.gov
  3. Staley BS, Robinson LR, Claussen AH, et al. Attention-deficit/hyperactivity disorder diagnosis, treatment, and telehealth use in adults: National Center for Health Statistics Rapid Surveys System, United States, October to November 2023. MMWR Morbidity and Mortality Weekly Report. 2024;73(40):890-895. doi:10.15585/mmwr.mm7340a1
  4. Abramovitch A, Dar R, Mittelman A, Wilhelm S. Comorbidity between attention deficit/hyperactivity disorder and obsessive-compulsive disorder across the lifespan: a systematic and critical review. Harvard Review of Psychiatry. 2015;23(4):245-262. doi:10.1097/HRP.0000000000000050
  5. Bohall BS, Gorbis A, Gorbis E. Impulsivity and compulsivity in obsessive-compulsive spectrum disorders: clinical implications for treatment sequencing. Cureus. 2026;18(4):e107663. doi:10.7759/cureus.107663
  6. Guzick AG, McNamara JPH, Reid AM, et al. The link between ADHD-like inattention and obsessions and compulsions during treatment of youth with OCD. Journal of Obsessive-Compulsive and Related Disorders. 2017;12:1-8. doi:10.1016/j.jocrd.2016.11.004
  7. Grigaitytė J, Strumila R. A narrative review of augmentation strategies in obsessive-compulsive disorder: antipsychotics as mainstay and emerging role of extended-release methylphenidate. Pharmaceuticals. 2026;19(4):551. doi:10.3390/ph19040551
  8. U.S. Food and Drug Administration. Adderall XR (mixed salts of a single-entity amphetamine product) prescribing information. Revised 2026. accessdata.fda.gov
  9. U.S. Food and Drug Administration. Strattera (atomoxetine) prescribing information. 2022. accessdata.fda.gov
  10. U.S. Food and Drug Administration. Zoloft (sertraline hydrochloride) prescribing information. Revised 2023. accessdata.fda.gov